Dupuytren disease is a common condition that causes progressive finger contractures resulting in impaired hand function and difficulties in performing daily activities. Patient reported outcome measures (PROMs) are commonly used in research and clinical practice to evaluate treatment outcomes. Both general upper extremity PROMs and Dupuytren-specific PROMs are available, typically developed using conventional methodology based on classical test theory. However, most current PROMs have been shown to have low responsiveness and the relevance of included items have been questioned. In this study we aim to develop a new Dupuytren-specific PROM using modern measurement methodology based on item response theory (IRT). The study will be performed in three phases. In Phase 1, (completed), an expert group developed a questionnaire with a large number of potentially relevant items derived from existing PROMs and patient collaboration. In Phase 2, the questionnaire will be administered to 300 patients with Dupuytren disease, and their responses will be analyzed with IRT methodology to identify the best performing items to be included in the new PROM. In Phase 3, the new PROM will be administered to 300 additional patients for validation. This new Dupuytren-specific patient-reported outcome measure will help advance clinical research on Dupuytren disease.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/14604582241301642 | DOI Listing |
Plast Reconstr Surg
December 2024
Department of Plastic and Reconstructive Surgery.
Background: Dupuytren's disease (DD) is a type of fibroproliferative disease that involves the palmar aspect of the hand. Although many benign fibroproliferative diseases have been shown to increase the risk of cardiovascular disease, the relationship between DD and myocardial infarction (MI) or stroke has not been fully elucidated.
Methods: A total of 35,909 patients with DD and a control cohort with 1,077,270 age- and sex-matched participants from the Korean National Health Insurance database were included.
Hand (N Y)
December 2024
Department of Surgery, Division of Plastic Surgery, McMaster University, Hamilton, ON, Canada.
Background: Currently, there is no recommended standard set of outcomes to report in Dupuytren disease treatment studies, nor are there guidelines on how the outcomes themselves should be reported. This study aimed to elicit the most salient issues for patients living with and undergoing treatment for Dupuytren disease, as well as for the hand surgeons, occupational therapists, and physical therapists caring for these patients.
Methods: A qualitative, interpretive description study employing one-on-one semi-structured interviews was conducted.
Plast Reconstr Surg
January 2025
From the Division of Plastic and Reconstructive Surgery, Emory University School of Medicine.
Hand Ther
December 2024
South Wing E1 Orthopaedic Outpatients, Dorset County Hospital, Dorchester, UK.
Background: Hand surgery is commonly required for conditions like Dupuytren's disease, carpal tunnel syndrome, and carpometacarpal osteoarthritis. Hand experts agree that patient education and managing expectations can optimise surgical outcomes. With an aging population, and rising rates of diabetes and obesity, a significant increase in elective hand surgeries is anticipated over the next decade.
View Article and Find Full Text PDFEur J Prev Cardiol
December 2024
Department of Cardiology, Dupuytren University Hospital, 2, Martin Luther King Ave, 87042 Limoges, France.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!